SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey

MLA

Shanta Dutta, et al. “SARS-CoV-2 Antibody Seroprevalence in India, August–September, 2020: Findings from the Second Nationwide Household Serosurvey.” The Lancet Global Health, vol. 9, Mar. 2021, pp. e257–66. EBSCOhost, https://doi.org/10.1016/s2214-109x(20)30544-1.

APA

Shanta Dutta, Harpreet Singh Pawar, Giridhara R Babu, V. Saravanakumar, Kanwar Narain, Ezhilarasan Ilayaperumal, Sanjay Zodpey, Babu Jagjeevan, Swarup Sarkar, Srikanta Kanungo, Tekumalla Ramarao, Vijay K. Shukla, Jaya Singh Kshatri, Ashrafjit S. Chahal, Aparup Das, Balram Bhargava, Hari Bhan Singh, R Anusha, Chethana Rangaraju, … K. Nagbhushanam. (2021). SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey. The Lancet Global Health, 9, e257–e266. https://doi.org/10.1016/s2214-109x(20)30544-1

Chicago

Shanta Dutta, Harpreet Singh Pawar, Giridhara R Babu, V. Saravanakumar, Kanwar Narain, Ezhilarasan Ilayaperumal, Sanjay Zodpey, et al. 2021. “SARS-CoV-2 Antibody Seroprevalence in India, August–September, 2020: Findings from the Second Nationwide Household Serosurvey.” The Lancet Global Health 9 (March): e257–66. doi:10.1016/s2214-109x(20)30544-1.